← Open Payments lookup

EMILY TURNER: Open Payments

NPI 1013329218 · LOWELL, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$707 in 45 payments from 16 companies in 2025. Trend: 2023 $597 · 2024 $552 · 2025 $707

Food & beverage: $707
CompanyPaymentsAmount
Amgen Inc.13$155
Merck Sharp & Dohme LLC5$82
Novartis Pharmaceuticals Corporation5$81
PFIZER INC.4$64
E.R. Squibb & Sons, L.L.C.4$57
Bayer Healthcare Pharmaceuticals Inc.2$39
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$37
Alnylam Pharmaceuticals Inc.2$30
Alkermes, Inc.1$27
Verona Pharma, Inc.1$25

Products named: REPATHA, VERQUVO, ELIQUIS, LEQVIO, Kerendia, CAPLYTA, AMVUTTRA, CAMZYOS.

Industry payments across AR — which companies pay providers there.